5-(n-methyl-n-isobutyl)amiloride has been researched along with Heart Disease, Ischemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karmazyn, M; Li, GH; Mathur, S; Myers, ML | 1 |
| Karmazyn, M; Moffat, MP | 1 |
| Maddaford, TG; Pierce, GN | 1 |
3 other study(ies) available for 5-(n-methyl-n-isobutyl)amiloride and Heart Disease, Ischemic
| Article | Year |
|---|---|
Sodium-hydrogen exchange inhibitors improve postischemic recovery of function in the perfused rabbit heart.
Topics: Amiloride; Animals; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion; Perfusion; Rabbits; Sodium-Hydrogen Exchangers | 1995 |
Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-ischemic contractile dysfunction in rat and guinea-pig hearts.
Topics: Adenine Nucleotides; Amiloride; Animals; Creatine Kinase; Glycogen; Guinea Pigs; Heart; Heart Rate; Hydrogen-Ion Concentration; In Vitro Techniques; Ion Transport; Lactates; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchangers | 1993 |
Myocardial dysfunction is associated with activation of Na+/H+ exchange immediately during reperfusion.
Topics: Amiloride; Animals; Cardiotonic Agents; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchangers; Time Factors; Ventricular Dysfunction; Ventricular Function | 1997 |